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STAT1 and STAT3 mediate thrombin-induced expression of bin formation is expected in these conditions. Recent
TIMP-1 in human glomerular mesangial cells. research has demonstrated that thrombin is a potent
Background. Thrombin exhibits numerous biological effects renal growth factor under renal pathophysiological con-on glomerular resident cells, such as cell proliferation, release
ditions [2], and it might play an important role in theand synthesis of cytokines and collagen, expressions of metallo-
pathogenesis of proliferative glomerulonephritis. Theproteinases and their inhibitors, especially tissue inhibitor of
metalloproteinase-1 (TIMP-1). However, the signaling mecha- role of thrombin in the progressive chronic renal diseases
nisms underlying these cellular events have not been fully eluci- has not been fully understood. However, thrombin might
dated. The present study was designed to examine the role of well affect the pathophysiology of glomerulosclerosis,signal transducers and activators of transcription (STAT) in
the common pathway of various kidney diseases, by in-thrombin-induced TIMP-1 expression in human mesangial
fluencing the enzymes for matrix degradation [3]. It hascells.
Methods. Cultured human glomerular mesangial cells were been reported that thrombin promotes the expression
incubated with thrombin up to 12 hours. The effects of the of tissue-type inhibitor of metalloproteinase-1 (TIMP-1),
antisense of STAT1 and antisense of STAT3 on stimulated a potent inhibitor of the key matrix-degrading enzymes,TIMP-1 mRNA levels and DNA-binding activities of both
matrix metalloproteinases, in cultured human mesangialSTAT1 and STAT3 were determined using Northern blot, elec-
cells [4].trophoretic mobility shift assay (EMSA), and supershift assay.
Results. Cultured human mesangial cells constitutively ex- While thrombin is well known to initiate multiple sig-
pressed TIMP-1, and thrombin induced TIMP-1 gene transcrip- naling pathways via its receptors [5], which signaling
tion in a time- and dose-dependent manner. Hirudin, a specific pathway is involved in thrombin-induced TIMP-1 ex-inhibitor of thrombin, could block thrombin-induced TIMP-1
pression has not been determined. Signal transducersexpression. Thrombin also induced STAT-DNA binding activ-
and activators of transcription (STAT) is a recently char-ity in a similar time- and dose-dependent manner. In order
to examine the role of STAT in thrombin-induced TIMP-1 acterized signaling pathway that regulates many cellular
expression, STAT1 and STAT3 antisense oligonucleotides events induced by transforming growth factor- (TGF-),
were used. EMSA showed that STAT1 and STAT3 antisense tumor necrosis factor- (TNF-), erythropoietin (EPO),oligonucleotides could inhibit both thrombin-induced STAT-
interleukins (IL), etc. Thrombin stimulates STAT-DNADNA binding activities and TIMP-1 mRNA expression; the
binding activity in rat aortic smooth muscle cells and hu-supershift assay showed that the SIF band consisted of STAT1
and STAT3 proteins. man platelets, but inhibits STAT3 signaling induced by
Conclusions. Both STAT1 and STAT3 may be involved, at IL-6, leukemia inhibitory factor, and ciliary neurotrophic
least in part, in thrombin-induced expression of the TIMP-1 factor in CCL39 cells [6]. Since the binding site forgene in cultured human mesangial cells.
STAT3 has been found in the promoter region of the
TIMP-1 gene [7], we hypothesized that thrombin-induced
TIMP-1 expression is mediated through the STAT path-Glomerular fibrin deposition is a documented feature
way, and tested this premise in the present study.of numerous renal diseases characterized by severe renal
tissue injury [1]. Thus, excessive intraglomerular throm-
METHODS
Glomerular mesangial cell isolation and culture
Key words: thrombin, tissue inhibitor of metalloproteinase-1, STAT1,
STAT3, glomerular mesangial cells. Human glomerular mesangial cells were isolated from
adult kidneys unsuitable for transplantation due to im-Received for publication March 27, 2001
munological reasons and cultured in RPMI 1640 (Gibco-and in revised form October 23, 2001
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mycin at 37C in 5% CO2. The cells were identified by 5-CCA CTG AGA CAT CCT GCC ACC-3 and the
corresponding sense oligonucleotide sequence was 5-their typical stellate morphology at subconfluence and
typical hillocks at confluence, and were positively stained GGT GGC AGG ATG TCT CAG TGG-3. The STAT
3 antisense oligonucleotide sequence was 5-CCA TTGfor actin, myosin, and type IV collagen, but negative for
cytokeratin and factor VIII, by immunofluorescence [8]. GGC CAT CCT GTT TCT-3 and the corresponding
sense oligonucleotide sequence was 5-AGA AAC AGGCells between passages 3 and 5 were used for the experi-
ments. The cells at 80% confluence were deprived of ATG GCC CAA TGG-3. In addition, the scrambled
oligonucleotide sequence was CAA ATG GGC TCCserum for 12 hours, and then stimulated with thrombin
in a serum-free RPMI 1640 medium for 6 to 12 hours. GAC GTC GGT.
To evaluate the role of STAT1 and STAT3 in throm-The final concentrations of thrombin were 0.5, 1.5, and
4.5 U/mL, respectively, and 9.0 U/mL of hirudin (Sigma), bin-induced TIMP-1 expression, subconfluent mesangial
cells were deprived of serum for 12 hours, followed bya specific inhibitor of thrombin was used when indicated.
For time courses assays, cells were harvested after being changing the medium to serum-free RPMI 1640 con-
taining 3 mol/L antisense oligonucleotides in 10 mg/mLincubated with thrombin (4.5 U/mL) for 0.5, 1, 3, 6, and
12 hours, respectively. lipofectin and incubated for 10 hours before adding
thrombin. As controls, cells received serum-free RPMI
Northern blot analysis of thrombin-induced expression 1640 medium containing lipofectin with/without 3 mol/L
of TIMP-1 mRNA in glomerular mesangial cells sense, or scrambled oligonucleotides.
Total cell RNA was extracted with Trizol reagent
Preparation of nuclear proteins(Gibco-BRL) according to the manufacturer’s instruc-
tion. Briefly, cells were rinsed three times with cold phos- The nuclear protein extracts were obtained according
to the method of Dignam, Lebovitz and Roeder, withphate-buffered saline (PBS) solution, 0.8 mL Trizol solu-
tion was added into the flask, and stood on ice for 15 some modifications [10]. Briefly, cells were rinsed twice
with cold PBS, scraped with a rubber policeman andminutes. The cell lysates were transferred into sterile
centrifugation tubes, mixed with chloroform, and centri- transferred to microcentrifuge tubes. Cell pellets were
suspended in 400 L cold buffer A [10 mmol/L HEPESfuged at 12,000 rpm for 15 minutes at 4C. The upper
transparent layer was transferred to another centrifuge pH 7.9, 1.5 mmol/L MgCl2, 10 mmol/L KCl, 0.5 mmol/L
dithiothreitol (DTT), 0.2 mmol/L phenylmethylsulfonyltube and mixed with equal volume of isopropanol, fol-
lowed by centrifugation again at 4C. The RNA pellets fluoride (PMSF)] and left on ice for efficient cell swelling,
followed by a centrifugation for 10 seconds. Nuclearwere dissolved in DEPC-treated water and quantified
with spectrophotometer. Twenty micrograms of total pellets were re-suspended again in 40 L cold buffer C
[20 mmol/L HEPES pH 7.9, 25% glycerol, 420 mmol/LRNA were electrophoresed on 1% agarose gel con-
taining 2.2% formaldehyde and transferred onto nylon NaCl, 1.5 mmol/L MgCl2, 0.2 mmol/L ethylenediamine-
tetraacetic acid (EDTA), 0.5 mM DTT, 0.2 mmol/Lmembrane (Hybond; Amersham) by capillary blotting,
cross-linked in a ultraviolet cross-linker, pre-hybridized, PMSF) and incubated on ice for 30 minutes. After cen-
trifugation at 12,000 rpm for two minutes at 4C, theand then hybridized with 32P-labeled human TIMP-1
probe. The probe was prepared by reverse transcription- concentrations of the supernatant proteins were deter-
mined. Aliquots of the nuclear proteins were stored atpolymerase chain reaction (RT-PCR). The primers used
for RT-PCR are as follows: human TIMP-1 sense se- 70C until use.
quence, 5-TTG AAT TCC CAC CAT GGC CCC CTT
Electrophoretic mobility shift assayTGA GCC-3; antisense, 5-GCA GGA TTC AGG
CTA TCT GGG ACC GCA-3. The PCR products were Electrophoretic mobility shift assay (EMSA) was car-
ried out according to previous methods with modificationpurified with glassmilk (Bio-Rad) and identified by DNA
sequencing. [11]. The double-stranded STAT consensus oligonucleo-
tides probe used in this study was m67 (5-CATTTCCC
Antisense oligodeoxynucleotide studies GTAAATC-3), which binds STAT1 and STAT3 [11],
was end-labeled with -32P-ATP by T4 polynucleotidePhosphorothioated 21-mer oligodeoxynucleotides for
STAT 1 and STAT3 were synthesized on an Applied kinase (Gibco-BRL) according to the manufacturer’s
protocol. For binding reaction, 50,000 cpm of the end-Biosystem 394 synthesizer by using -cyanothylphys-
phoramide chemistry to minimize degradation of the labeled STAT1 or STAT3 probe was co-incubated with
a cocktail of 20 g nuclear proteins in gel shift bindingoligonucleotides by endogenous nucleases. The anti-
sense oligonucleotides were directed against the transla- buffer (10 mmol/L Tris-HCl, pH 7.5, 50 mmol/L NaCl,
4% glycerol, 1.0 mmol/L MgCl2, 5.0 mmol/L EDTA, 0.5tion start site (AUG codon) and surrounding nucleotides
of the human STAT1 gene and STAT3 gene, respectively mmol/L DTT) and 2 g poly (dI-dC) at room tempera-
ture for 30 minutes. EMSAs were performed on non-[9]. The STAT 1 antisense oligonucleotide sequence was
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Fig. 1. Thrombin induced tissue inhibitor of metalloproteinase-1
(TIMP-1) in a dose-dependent manner. Cells were harvested after incu-
bation with thrombin and/or hirudin for six hours. Lanes are: (1) control;
(2–4) cells incubated with thrombin at 0.5, 1.5, and 4.5 U/mL, respec-
tively; (5) cells treated with thrombin 4.5 U/mL plus hirudin 9 U/mL;
(6) cells incubated with hirudin 9 U/mL only.
Fig. 3. Thrombin induced STAT-DNA binding in a dose-dependent
manner. Cells were harvested after incubation with thrombin for six
hours. Lanes are: (1) control; (2–5) cells incubated with thrombin at
0.5, 1.5, 3.0 and 4.5 U/mL, respectively. In lane 6, a 50-fold molar excess
of unlabeled competitor probe was added as a cold competitor. Lanes
7–9, the radiolabeled m67 probe mutants 1, 2, and 3 did not form
complexes with nuclear extracts from 4.5 U/mL thrombin-treated cells.
Polyclonal anti-STAT1 (lane 10) or anti-STAT3 (lane 11) antibodies
were added to nuclear extracts from cells pretreated with 4.5 U/mL
thrombin prior to the addition of the probes. The sis-inducible factor
(SIF) complex and the supershifted complex are indicated by the as-
terisk.
Fig. 2. Thrombin induced TIMP-1 mRNA expression in a time-depen-
dent manner. Cells were harvested after incubation with 4.5 U/mL
thrombin for 0 hour (lane 1), 0.5 hours (lane 2), 1 hour (lane 3), 3 hours
(lane 4), 6 hours (lane 5), and 12 hours (lane 6). RESULTS
Thrombin induced TIMP-1 mRNA expression
Human glomerular mesangial cells constitutively ex-
pressed TIMP-1 mRNA. Thrombin up-regulated TIMP-1denaturing 4% polyacrylamide gel in 0.5  TBE buffer
gene expression in both dose- and time-dependent man-at 100 V. Dried gels were subjected to autoradiography
ners, and this could be inhibited by hirudin, a specificat 70C. As controls, unlabeled oligonucleotides at 50-
inhibitor of thrombin. Levels of TIMP-1 mRNA ex-fold molar excess were included. In addition, three oligo-
pressed by cells treated with 0.5, 1.5, and 4.5 U/mLnucleotides incorporating distinct mutations, insertions,
thrombin were 1.5-, 2.8-, and 4.4-fold those of the controlor deletions in the above STAT consensus oligonucleo-
group. Cells treated with 4.5 U/mL thrombin togethertides were also end-labeled to be used as radiolabeled
with 9.0 U/mL hirudin induced a less pronounced in-
probes. These mutant STST probes, with mutated nucle-
crease of TIMP-1 mRNA compared with that in the
otide(s) in italics, were: MUT1, 5-CATTTCCCGTAA control (Fig. 1). The expression of TIMP-1 expression
ATC-3; MUT2, 5-CATTTCCATGCATGCATCGTA peaked when the cells had been incubated for six hours
AATC-3; MUT3, 5-CATTT(X)AAATC-3. Each mu- with 4.5 U/mL thrombin (Fig. 2).
tant incorporated a distinct sort of change. MUT1 has a
one-nucleotide mutation in the 5 side of the m67 probe; Thrombin stimulated STAT-DNA binding activity
MUT2 has a 10-bp insertion separating the 5 and 3 To explore the possible participation of STATs in
sides of m67 probe; MUT3 deletes 5-bp between the 5 thrombin-induced TIMP-1 gene expression, EMSA was
and 3 sides of m67 probe. For supershift assays, nuclear performed to investigate the activity of STAT in human
extracts were preincubated with STAT1& polyclonal mesangial cells treated with or without thrombin. The
antibody (sc-346; Santa Cruz) and/or STAT3 polyclonal results showed that thrombin promoted STAT-DNA
antibody (sc-482; Santa Cruz) for 30 minutes on ice after binding activity in both dose- and time- dependent (Figs.
3 and 4). The outcome of applying cold or mutant com-the addition of the probe.
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Fig. 5. STAT1 antisense inhibited STAT-DNA binding activity in glo-
merular mesangial cells. Subconfluent mesangial cells were deprived of
serum for 12 hours, and the medium was changed to serum-free RPMIFig. 4. Thrombin-induced STAT-DNA binding in a time-dependent
1640, which contained 3 mol/L antisense oligonucleotides in 10 mg/mLmanner. Cells were harvested after being incubated with 4.5 U/mL
lipofectin and incubated for 10 hours before adding thrombin. As con-thrombin for 0 hour (lane 1), 0.5 hours (lane 2), 1 hour (lane 3), 3 hours
trols, cells received serum-free RPMI 1640 medium containing lipofectin(lane 4), 6 hours (lane 5). In lane 6, a 50-fold molar excess of unlabeled
with or without 3 mol/L sense, or scrambled oligonucleotides. Cellscompetitor probe was added as a cold competitor. Lanes 7–9, the radio-
were harvested after incubation with thrombin and/or hirudin for 6labeled m67 probe mutants 1, 2, and 3 did not form complexes with
hours. Lanes are: (1) control; (2) thrombin 4.5 U/mL; (3) thrombin 4.5nuclear extracts from 4.5 U/mL thrombin-treated cells. Polyclonal anti-
U/mL plus hirudin 9 U/mL; (4) antisense 3 mol/L; (5) sense 3 mol/L;STAT1 (lane 10) or anti-STAT3 (lane 11) antibodies were added to
(6) thrombin 4.5 U/mL plus antisense 3 mol/L; (7) thrombin 4.5 U/mLnuclear extracts from cells pretreated with 4.5 U/mL thrombin prior to
plus sense 3 mol/L; (8) 50-fold molar excess of unlabeled competitorthe addition of the probes. The sis-inducible factor (SIF) complex and
probe as cold probes; (lanes 9 to 11) radiolabeled mutant probes 1, 2the supershifted complex are indicated by the asterisk.
and 3; (12) scrambled oligonucleotides 3 mol/L; (13) anti-STAT1
antibody; (14) anti-STAT3 antibody.
petitor probes supported the specificity of the m67 probe
DISCUSSIONused. Supershift results demonstrated that the SIF band
consisted of STAT1 and STAT3. In order to determine Many glomerular diseases are characterized by accu-
mulation of extracellular matrix. Imbalance between itswhether STAT1 and STAT3 are involved in thrombin-
induced STAT-DNA binding activity, antisense oligonu- synthesis and degradation might contribute to the devel-
opment of glomerulosclerosis. Glomerular resident cellscleotides for STAT1 or STAT3 were added in the media
to suppress the corresponding activities, respectively. have the ability to synthesize and secret both matrix
metalloproteinases (MMPs) and tissue inhibitors of ma-EMSA showed that both STAT1 and STAT3 antisense
oligonucleotides significantly diminished the STAT- trix metalloproteinases (TIMPs) including TIMP-1, -2,
-3 and -4. Abnormal expression of these enzymes and/orDNA binding induced by thrombin, while the STAT1
or STAT3 sense or scrambled oligonucleotides had no their inhibitors may induce destruction or remodeling of
glomerular architecture under pathophysiological condi-such suppressing effects on thrombin-induced STAT-
DNA binding activity. The supershifted bands were tions [12–14].
TIMP-1 expression can be up-regulated in fibroblastsSTAT1 or STAT3 as indicated. (Figs. 5 and 6).
by a variety of soluble factors including interleukin-1
Role of STAT 1 and STAT 3 in thrombin-induced (IL-1), tumor necrosis factor- (TNF-), epidermal
TIMP-1 gene expression growth factor (EGF), transforming growth factor-
(TGF-) phorbol esters, and retinoic acid [15]. Recently,To further identify the relationship between STAT
activity and TIMP-1 gene expression, blocking experi- it has been reported that thrombin can increase the ex-
pression of TIMP-1 in cultured human mesangial cellsments were used in this study. The role of thrombin in
increasing TIMP-1 mRNA levels in human glomerular [4]. It is well known that thrombin initiates multiple
signaling pathways via its receptors [5]. However, it ismesangial cells was inhibited by pre-incubation of the
cells with STAT 1 or STAT 3 antisense oligonucleotides. still unknown which signaling pathway is involved in
thrombin-induced TIMP-1 expression. Signal transduc-STAT1 or STAT3 sense or scrambled oligonucleotides
had no effects on TIMP-1 mRNA expressions. (Fig. 7). ers and activators of transcription (STAT) is a recently
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Fig. 7. STAT1 and STAT3 antisense oligonucleotides inhibited throm-
bin-induced TIMP-1 mRNA expression in glomerular mesangial cells.
Cells were incubated in the serum-free RPMI 1640 containing 3 mol/L
antisense oligonucleotides in 10 mg/mL lipofectin and incubated for 10
hours before adding thrombin 4.5 U/mL. As controls, cells received
serum-free RPMI 1640 medium containing lipofectin with/without 3
mol/L sense, or scrambled oligonucleotides. Cells were harvested after
having been incubated with thrombin and/or hirudin for six hours.
Lanes are: (1) control; (2) thrombin 4.5 U/mL; (3) STAT3 antisense 3
mol/L; (4) STAT3 antisense 3 mol/L plus thrombin 4.5 U/mL; (5)
STAT3 sense (3 mol/L plus thrombin 4.5 U/mL); (6) STAT1 antisense
3 mol/L; (7) STAT1 antisense 3 mol/L plus thrombin 4.5 U/mL;
Fig. 6. STAT3 antisense also inhibited STAT-DNA binding activity in (8) STAT1 sense 3 mol/L plus thrombin 4.5 U/mL; (9) scrambled
glomerular mesangial cells. Cells were incubated in the serum-free oligonucleotide 3 mol/L.
RPMI 1640 containing 3mol/L antisense oligonucleotides in 10 mg/mL
lipofectin and incubated for 10 hours before adding thrombin 4.5 U/mL.
As controls, cells received serum-free RPMI 1640 medium containing
lipofectin with/without 3 mol/L sense, or scrambled oligonucleotides.
Cells were harvested after having been incubated with thrombin and/or thrombin promoted STAT activity in SMC, but were in
hirudin for six hours. Lanes are: (1) control; (2) thrombin 4.5 U/mL;
contrast to Bhat et al’s findings in CCL39 cells and lung(3) thrombin 4.5 U/mL plus hirudin 9 U/mL; (4) antisense 3 mol/L;
(5) sense 3 mol/L; (6) thrombin 4.5 U/mL plus antisense 3 mol/L; (7) fibroblasts [6, 17, 18]. The results of inhibition assay
thrombin 4.5 U/mL plus sense 3 mol/L; (8) 50-fold molar excess of
with antisense oligonucleotides of STAT1 or STAT3, inunlabeled competitor probe as cold probes; (lanes 9 to 11) radiolabeled
mutant probes 1, 2 and 3; (12) scrambled oligonucleotides 3 mol/L; combination with the results of the supershift assay with
(13) anti-STAT1 antibody; (14) anti-STAT3 antibody. polyclonal antibodies to STAT1 or STAT3, demon-
strated that the major DNA-binding components were
heterodimer STAT3/STAT1. In order to identify the
relationship between STAT activation and TIMP-1 gene
characterized signaling pathway that regulates many cel- expression induced by thrombin, Northern blot analysis
lular events induced by TGF-, TNF-, erythropoietin, was carried out to examine TIMP-1 mRNA levels in dif-
interleukins, and others. Activation of STAT proteins ferent transfected groups in the presence of thrombin. Our
has been reported in cells treated with various cytokines,
data showed that pre-incubation with STAT1 or STAT3growth factors, insulin, and angiotensin II [16]. Thrombin
antisense oligonucleotides also prevented thrombin in-stimulated STAT-DNA binding activity in rat aortic
duced TIMP-1mRNA expression.smooth muscle cells and human platelets, but inhibited
In summary, the present study suggests that STAT1STAT3 signaling induced by IL-6, leukemia inhibitory
and STAT3 can be activated by thrombin and, at leastfactor, and ciliary neurotrophic factor in CCL39 cells [6].
in part, be involved in thrombin-induced TIMP-1 mRNAIt has been reported that there is a binding site for
expression in human mesangial cells. This may be helpfulSTAT3 in the promoter region of the TIMP-1 gene [7].
Therefore, the present study was designed to test if in further understanding the pathophysiological behav-
thrombin-induced TIMP-1 expression might be medi- ior of thrombin in glomerular injury.
ated through STAT pathway.
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